Blockchain Registration Transaction Record

Creatd Sells Flyte Stake to NYSE-Listed VTAK, Securing $12M in Cash and Equity

Creatd sells 80% of Fly Flyte to Catheter Precision (VTAK) for $12M in cash and equity, boosting its balance sheet and advancing its national exchange listing strategy.

This transaction demonstrates a viable alternative model for small-cap companies seeking growth and exchange listings without dilutive traditional financing. For investors, it highlights Creatd's potential as a specialized platform that identifies undervalued assets, applies operational expertise, and executes premium exits—creating shareholder value through strategic M&A rather than speculative trading. In a market where many micro-cap companies struggle with infrastructure gaps, Creatd's approach could signal a new pathway for sustainable growth in the sector, potentially influencing how turnaround investments are structured and valued.